Artivion, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$3.2Mgeneral payments (2019-2025)
$241Kresearch payments (2019-2025)
2,454clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $474K
2020 $296K
2021 $630K
2022 $269K
2023 $386K
2024 $450K
2025 $670K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Thoracic Surgery (Cardiothoracic Vascular Surgery) $2.4M
Surgery $466K
Cardiovascular Disease $127K
Vascular Surgery $105K
Interventional Cardiology $34K
Pediatric Cardiology $12K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Sidney Levitsky Boston, MA Thoracic Surgery (Cardiothoracic Vascular Surgery) $247,549.25
Richard Engelman Springfield, MA Surgery $166,850.00
William Northrup White Bear Lake, MN Surgery $159,512.95
Marc Gerdisch Indianapolis, IN Thoracic Surgery (Cardiothoracic Vascular Surgery) $143,290.15
Glenn Barnhart Seattle, WA Thoracic Surgery (Cardiothoracic Vascular Surgery) $123,239.53
Shinichi Fukuhara Ann Arbor, MI Thoracic Surgery (Cardiothoracic Vascular Surgery) $90,123.54
Mario Castillo-Sang Edgewood, KY Thoracic Surgery (Cardiothoracic Vascular Surgery) $85,207.52
Eric Roselli Cleveland, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $74,665.86
Kyle Eudailey Birmingham, AL Thoracic Surgery (Cardiothoracic Vascular Surgery) $64,914.10
Fernando Fleischman Los Angeles, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $56,481.44

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.